Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Spiked Supplements Prompt Fraud, Money Laundering Charges

This article was originally published in The Tan Sheet

Executive Summary

An FDA-assisted investigation led to a federal indictment in Utah against the founder of ingredient supplier NovaCare LLC on charges linked to dietary supplements adulterated with an analogue of an ingredient indicated for erectile dysfunction.

You may also be interested in...



Spiked Supplement Penalties May Predict Stronger Enforcement Approach

FDA and DoJ imposed a financial penalty and a prison sentence on the founder of NovaCare LLC, who pleaded guilty to spiking supplements. Industry stakeholders say the penalties could be a sign of coming enforcement strategy as FDA runs out of patience with spiked supplements.

Spiked Supplement Penalties May Predict Stronger Enforcement Approach

FDA and DoJ imposed a financial penalty and a prison sentence on the founder of NovaCare LLC, who pleaded guilty to spiking supplements. Industry stakeholders say the penalties could be a sign of coming enforcement strategy as FDA runs out of patience with spiked supplements.

FDA Warning Letters In Brief

NovaCare cited for Viagra analogue

Related Content

Topics

UsernamePublicRestriction

Register

PS105334

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel